Fewer Bronchiectasis Exacerbations During the "Lockdown" for COVID-19: Can We Convert Knowledge into Action?

Overview

Journal Am J Respir Crit Care Med

Specialty Critical Care

Date 2021 Aug 12

PMID 34384044

Citations 5

Authors

Mark L Metersky

Affiliations

Soon will be listed here.

Citing Articles

Symptoms and medical resource utilization of patients with bronchiectasis after SARS-CoV-2 infection.

Wang J, Ren J, Li X, Wang J, Chang C, Sun L Front Med (Lausanne). 2024; 10:1276763.

PMID: 38264053 PMC: 10804846. DOI: 10.3389/fmed.2023.1276763.

Treatment adherence and anxiety levels of bronchiectasis patients in the COVID-19 pandemic.

Borekci S, Vardaloglu I, Gungordu N, Caliskaner Ozturk B, Culpan H, Aksoy Poyraz C Medicine (Baltimore). 2023; 102(19):e33716.

PMID: 37171358 PMC: 10173943. DOI: 10.1097/MD.0000000000033716.

Short and Long-Term Impact of COVID-19 Infection on Previous Respiratory Diseases.

Chiner-Vives E, Cordovilla-Perez R, de la Rosa-Carrillo D, Garcia-Clemente M, Izquierdo-Alonso J, Otero-Candelera R Arch Bronconeumol. 2022; 58 Suppl 1:39-50.

PMID: 35501222 PMC: 9012323. DOI: 10.1016/j.arbres.2022.03.011.

Chronic respiratory diseases other than asthma in children: the COVID-19 tsunami.

Di Cicco M, Tozzi M, Ragazzo V, Peroni D, Kantar A Ital J Pediatr. 2021; 47(1):220.

PMID: 34742332 PMC: 8571868. DOI: 10.1186/s13052-021-01155-9.

Exacerbation of bronchiectasis by complicating COVID-19 disease: A case report.

Georgakopoulou V, Avramopoulos P, Papalexis P, Bitsani A, Damaskos C, Garmpi A Exp Ther Med. 2021; 22(6):1452.

PMID: 34721694 PMC: 8549101. DOI: 10.3892/etm.2021.10887.

References

Jain S, Self W, Wunderink R, Fakhran S, Balk R, Bramley A . Community-Acquired Pneumonia Requiring Hospitalization among U.S. Adults. N Engl J Med. 2015; 373(5):415-27. PMC: 4728150. DOI: 10.1056/NEJMoa1500245. View

Marriott D, Beresford R, Mirdad F, Stark D, Glanville A, Chapman S . Concomitant Marked Decline in Prevalence of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Other Respiratory Viruses Among Symptomatic Patients Following Public Health Interventions in Australia: Data from St Vincent's Hospital and.... Clin Infect Dis. 2020; 72(10):e649-e651. PMC: 7499558. DOI: 10.1093/cid/ciaa1256. View

Kitanovski S, Horemheb-Rubio G, Adams O, Gartner B, Lengauer T, Hoffmann D . Rhinovirus prevalence as indicator for efficacy of measures against SARS-CoV-2. BMC Public Health. 2021; 21(1):1178. PMC: 8215636. DOI: 10.1186/s12889-021-11178-w. View

Crichton M, Dudgeon E, Shoemark A, Chalmers J . Validation of the Bronchiectasis Impact Measure (BIM): a novel patient-reported outcome measure. Eur Respir J. 2020; 57(5). DOI: 10.1183/13993003.03156-2020. View

Choi S, Hong S, Ko G, Lee Y, Park H, Park S . Viral infection in patients with severe pneumonia requiring intensive care unit admission. Am J Respir Crit Care Med. 2012; 186(4):325-32. DOI: 10.1164/rccm.201112-2240OC. View

Mac Aogain M, Tiew P, Hou Lim A, Low T, Tan G, Hassan T . Distinct "Immunoallertypes" of Disease and High Frequencies of Sensitization in Non-Cystic Fibrosis Bronchiectasis. Am J Respir Crit Care Med. 2018; 199(7):842-853. DOI: 10.1164/rccm.201807-1355OC. View

Gao Y, Guan W, Xu G, Lin Z, Tang Y, Lin Z . The role of viral infection in pulmonary exacerbations of bronchiectasis in adults: a prospective study. Chest. 2014; 147(6):1635-1643. PMC: 7094490. DOI: 10.1378/chest.14-1961. View

Magge A, Ashraf S, Quittner A, Metersky M . Quality of life in patients with bronchiectasis: a 2-year longitudinal study. Ann Transl Med. 2019; 7(14):334. PMC: 6694265. DOI: 10.21037/atm.2019.06.62. View

Crichton M, Shoemark A, Chalmers J . The Impact of the COVID-19 Pandemic on Exacerbations and Symptoms in Bronchiectasis: A Prospective Study. Am J Respir Crit Care Med. 2021; 204(7):857-859. PMC: 8528525. DOI: 10.1164/rccm.202105-1137LE. View

10.

Metersky M, Aliberti S, Feldman C, Luna C, Shindo Y, Sotgiu G . Never Let a Good Crisis Go to Waste. Chest. 2021; 159(3):917-919. PMC: 9748788. DOI: 10.1016/j.chest.2020.10.018. View

11.

Chalmers J, Aliberti S, Polverino E, Vendrell M, Crichton M, Loebinger M . The EMBARC European Bronchiectasis Registry: protocol for an international observational study. ERJ Open Res. 2016; 2(1). PMC: 5005162. DOI: 10.1183/23120541.00081-2015. View

12.

Faria N, Costa M, Gomes J, Sucena M . Reduction of Severe Exacerbations of COPD during COVID-19 Pandemic in Portugal: A Protective Role of Face Masks?. COPD. 2021; 18(2):226-230. DOI: 10.1080/15412555.2021.1904387. View

13.

Dadras O, Alinaghi S, Karimi A, MohsseniPour M, Barzegary A, Vahedi F . Effects of COVID-19 prevention procedures on other common infections: a systematic review. Eur J Med Res. 2021; 26(1):67. PMC: 8253677. DOI: 10.1186/s40001-021-00539-1. View

14.

de Boer G, Braunstahl G, Hendriks R, Tramper-Stranders G . Asthma exacerbation prevalence during the COVID-19 lockdown in a moderate-severe asthma cohort. BMJ Open Respir Res. 2021; 8(1). PMC: 8102860. DOI: 10.1136/bmjresp-2020-000758. View